Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Valproate in McArdle Disease
NCT03112889Phase 2Completed
- Sponsor
- University College London
- Start
- Jan 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of valproic acid in Glycogen storage disease type 5 (GSD5), sponsored by University College London. Started Jan 2015; status: completed.
02
Drugs
valproic acid
03
Conditions
Glycogen storage disease type 5 (GSD5)
Beyond the preview
Go deeper on NCT03112889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03112889.